Robert Rissman

Dr. Rissman received his graduate degree in Neuroscience from Drexel University College of Medicine in 2001. He completed postgraduate training at the University of California, Irvine, and at The Salk Institute, before joining the UC San Diego Department of Neurosciences in 2008. Dr. Rissman’s lab in the School of Medicine at UC San Diego is focused on biomarker discovery in neurodegenerative diseases such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) using banked human samples and animal models.

In addition to research at UC San Diego, Dr. Rissman is a Principal Investigator at the Veterans Administration San Diego. In addition to basic science translational research, Dr. Rissman is the Director for UC San Diego’s Alzheimer’s Disease Cooperative Study (ADCS) Biomarker Core and Alzheimer’s Disease Research Center (ADRC) Neuropathology Core. Dr. Rissman is also the founding Director of the Alzheimer’s Therapeutic Research Institute (ATRI) Biomarker Laboratory and Biorepository, and Alzheimer’s Clinical Trial Consortium (ACTC) Biomarker Unit Lead.